With growth in percutaneous fixes for the valve, surgeons at STS 2025 called for innovation, team-based care, and more data.

Due to uncertainty within the data, the impact of looser driving restrictions still merits close scrutiny, a researcher says.

An analysis of the PURE study shows some gains but “little to no improvement in most places over time,” says Philip Joseph.

The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.

A new study comparing multiple and single arterial grafting highlights how physician preference can bias observational data.

Sreekanth Vemulapalli asks Ryan Ahern about potential data sources that can be used to sustain long-term follow-up in pivotal ...

January saw almost every major cardiovascular subspecialty represented among our most-clicked stories of the month.